N4 Pharma Share Discussion Threads

[nobbygnome] 18/11/2018 17:09

>> anne

You can probably short via Spreadex. I haven't tried but you can short most shares through them.

[ch1rp] 18/11/2018 16:58

For the naysayers, N4P actually has a creditable product which will advance the scope of gene therapy in the fight against cancer.""The Company is pleased to announce that MedImmune has confirmed its committment to investigating non-lipid nanoparticle technologies for mRNA and pDNA delivery and its intention to continue to work with N4 Pharma to conduct further ongoing research with a view to agreeing terms for co-development of an optimised version of Nuvec(R) under an appropriate collaboration agreement.This news is REAL. Its not conveniently wrong because some holders have been burnt or someone wishes to boost or reduce the share price. Gene therapy is here and nuvec will be the platform for more advanced future care.

[thaohemmings4] 16/11/2018 13:42

Its just a game and we don't know whenever it's up or down , massive rise or massive drop I just guess that for fun . I knew it's gone up 200% for a few week , will drop back down for some but who knows one beautiful day will go up massive again ? !

[unconscious] 16/11/2018 12:54

Well, it did drop back over 50% after the big rise in February and I doubt many anticipated that.AIM constantly throws curve balls so who knows eh. Another fall like that would take it to around 7p this time.

[flashheart] 16/11/2018 12:50

Good luck with that lol.

[anneagarg] 16/11/2018 12:47

How do you short the shares? which platform do you use?

[thaohemmings4] 16/11/2018 11:49

Going 50% soon

[ch1rp] 16/11/2018 09:34

Held on to a 100% rise in the last week. No one believes this is heading back to 5p.The only way is up. Mms collecting shares waiting for the rns:)))

[ch1rp] 15/11/2018 10:32

blue finniisshhhhhh.........:)))

[splatted] 15/11/2018 10:16

Well a profit is a profit.can't blame em!

[dave4545] 15/11/2018 09:43

Great, I'm trying to buy more but it's NT to buy all the time

[takethat] 15/11/2018 09:41

Just shorted SKIN at .5p

[dave4545] 15/11/2018 09:33

Potential next flier ticker SKIN...£1.4 mil market cap with rapidly increasing sales
and moving to break even

[thaohemmings4] 15/11/2018 08:47

More news coming soon and it will go up double price

[ch1rp] 15/11/2018 07:40

As nuvec evolves, NT will continue to lock up the patents here. They KNOW what they are doing:)))

[jakleeds] 15/11/2018 07:37

UK Regulatory (RNS & others)


TIDMN4P

RNS Number : 4038H

N4 Pharma PLC

15 November 2018

15 November 2018

N4 Pharma Plc

("N4 Pharma" or the "Company")

Filing of further Nuvec(R) patent application

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments, is pleased to announce the filing of its Patent Cooperation Treaty ("PCT") patent application for its novel delivery system, Nuvec(R).

Nuvec(R) is licensed by the Company from the University of Queensland under their silica nanoparticle patent application, which is currently under prosecution before various national patent offices. The patent application that was filed by the Company is based on improvements made to the manufacturing process, as the Company has scaled up production alongside specific examples of how Nuvec(R) can be used to improve delivery of nucleic acids.

The Company's new PCT patent application claims priority from the Company's United Kingdom patent application number 1718817.8. The PCT application will publish approximately 18 months from the priority date of 14 November 2017. Therefore publication is expected on or shortly after 14 May 2019. National phase entry is due 30 months from the priority date, in most countries. The national phasing deadline is therefore expected to be 14 May 2020.

Nigel Theobald, CEO of N4 Pharma commented:

"Having strong intellectual property for Nuvec(R) is important for commercial outlicensing and this new PCT patent application not only strengthens the intellectual property rights around Nuvec(R) but, if granted, would provide an extra 30 months protection for Nuvec(R) after expiry of the in licensed IP which, if granted, would likely expire in April 2036.

"As our work on Nuvec(R) progresses,we anticipate that subsequent patent applications will be filed to extend the protection for Nuvec(R) even further."

Enquiries:



N4 Pharma Plc
Nigel Theobald, CEO Via Alma PR
Allenby Capital Limited Tel: [phone]
James Reeve/Virginia Bull/Asha
Chotai
Alma PR
Josh Royston Tel: [phone]
Robyn Fisher Tel: [phone]

[fireball xl5] 14/11/2018 14:20

And the bounce. Where to next? Nuvec news cannot be far away.

The research program will not result in any financial benefit to the Company and the limited costs of the research, which are not expected to exceed GBP30,000, will be borne by N4 Pharma. Phase 1 is to test the delivery efficacy of combining the UoA cytolytic DNA vaccine with Nuvec(R) and will take around 4 weeks before proceeding into actual immunogenicity studies using different models, which would take a further 24 weeks.

That is if they release the results of the efficacy or just roll on into the studies.

[stealive] 14/11/2018 14:03

OEX bouncing back

[ch1rp] 14/11/2018 12:06

Agreed Splatted. Nothing wrong with the company nor where it is going. Just not today. Fortune will favour the LTHs:)))

[splatted] 14/11/2018 11:45

Its a classic trap for newbies,and most of them will never return.their only solace is that they got spiked on a good company.

[jimbobaroony] 14/11/2018 10:43

anyone managed to buy these this morning? My order with DEGIRO has not been filled yet a dummy selftrade order looks like it would go through.

[dave4545] 14/11/2018 09:45

Predictable.

I still cannot understand what draws so many to chase spikes so high. I mean paying 15p when it was 5p a few weeks ago why risk it in this market.

Hundreds of stocks at their lows but nobody will touch them, mark them up 100-200% in a week or two and people cannot buy them fast enough.

One day there will be no money left in this penny market, the mm's will have took it all, they suck millions out from people every week, it cannot sustain

[a1samu] 14/11/2018 09:38

Yea, certain loss for PI's and Xmas bonus for market makers, who should be obliged to explain any out of the ordinary movement in the price!